Latest Kynam Capital Management, LP Stock Portfolio
Kynam Capital Management, LP Performance:
2024 Q3: 14.59%YTD: 38.89%2023: 4.66%
Performance for 2024 Q3 is 14.59%, and YTD is 38.89%, and 2023 is 4.66%.
About Kynam Capital Management, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Kynam Capital Management, LP reported an equity portfolio of $1.3 Billions as of 30 Sep, 2024.
The top stock holdings of Kynam Capital Management, LP are NTRA, PCVX, CLDX. The fund has invested 19.9% of it's portfolio in NATERA INC and 9.1% of portfolio in VAXCYTE INC.
They significantly reduced their stock positions in PROTAGONIST THERAPEUTICS INC (PTGX), TRAVERE THERAPEUTICS INC (TVTX) and TYRA BIOSCIENCES INC (TYRA). Kynam Capital Management, LP opened new stock positions in BEAM THERAPEUTICS INC (BEAM) and ENGENE HOLDINGS INC. The fund showed a lot of confidence in some stocks as they added substantially to CG ONCOLOGY INC, LIQUIDIA CORPORATION (LQDA) and IRONWOOD PHARMACEUTICALS INC (IRWD).
The top stock holdings of Kynam Capital Management, LP are NTRA, PCVX, CLDX. The fund has invested 19.9% of it's portfolio in NATERA INC and 9.1% of portfolio in VAXCYTE INC.
They significantly reduced their stock positions in PROTAGONIST THERAPEUTICS INC (PTGX), TRAVERE THERAPEUTICS INC (TVTX) and TYRA BIOSCIENCES INC (TYRA). Kynam Capital Management, LP opened new stock positions in BEAM THERAPEUTICS INC (BEAM) and ENGENE HOLDINGS INC. The fund showed a lot of confidence in some stocks as they added substantially to CG ONCOLOGY INC, LIQUIDIA CORPORATION (LQDA) and IRONWOOD PHARMACEUTICALS INC (IRWD).
Kynam Capital Management, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Kynam Capital Management, LP made a return of 14.59% in the last quarter. In trailing 12 months, it's portfolio return was 70.7%.
New Buys
| Ticker | $ Bought |
|---|---|
| beam therapeutics inc | 31,901,100 |
| engene holdings inc | 11,459,100 |
New stocks bought by Kynam Capital Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| cg oncology inc | 3,184 |
| liquidia corporation | 147 |
| ironwood pharmaceuticals inc | 124 |
| viridian therapeutics inc | 43.5 |
| caribou biosciences inc | 43.08 |
| vaxcyte inc | 37.98 |
| wave life sciences ltd | 23.24 |
| dynavax technologies corp | 17.65 |
Additions to existing portfolio by Kynam Capital Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| protagonist therapeutics inc | -42.95 |
| travere therapeutics inc | -32.16 |
| tyra biosciences inc | -17.43 |
| cogent biosciences inc | -0.22 |
Kynam Capital Management, LP reduced stake in above stock
Sold off
Sector Distribution
Kynam Capital Management, LP has about 93.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 93.4 |
| Others | 6.6 |
Market Cap. Distribution
Kynam Capital Management, LP has about 20.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 41.8 |
| MID-CAP | 27.8 |
| LARGE-CAP | 20.1 |
| UNALLOCATED | 6.6 |
| MICRO-CAP | 3.7 |
Stocks belong to which Index?
About 72.7% of the stocks held by Kynam Capital Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 72.7 |
| Others | 27.3 |
Kynam Capital Management, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Kynam Capital Management, LP
Kynam Capital Management, LP has 24 stocks in it's portfolio. About 81.5% of the portfolio is in top 10 stocks. CLDX proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for Kynam Capital Management, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AMRN | amarin corp plc | 0.60 | 12,414,600 | 7,782,730 | added | 2.13 | ||
| BCRX | biocryst pharmaceuticals inc | 5.29 | 9,085,370 | 69,048,800 | added | 2.93 | ||
| BEAM | beam therapeutics inc | 2.44 | 1,302,080 | 31,901,100 | new | |||
| BNR | burning rock biotech ltd | 0.25 | 989,217 | 3,229,790 | added | 1.49 | ||
| CLDX | celldex therapeutics inc new | 9.01 | 3,458,610 | 117,558,000 | added | 2.05 | ||
| COGT | cogent biosciences inc | 7.65 | 9,239,730 | 99,789,100 | reduced | -0.22 | ||
| CRBU | caribou biosciences inc | 0.35 | 2,356,150 | 4,618,050 | added | 43.08 | ||
| DVAX | dynavax technologies corp | 7.12 | 8,332,690 | 92,826,100 | added | 17.65 | ||
| IRWD | ironwood pharmaceuticals inc | 1.16 | 3,685,560 | 15,184,500 | added | 124 | ||
| LQDA | liquidia corporation | 1.74 | 2,266,330 | 22,663,300 | added | 147 | ||
| NTRA | natera inc | 19.88 | 2,042,470 | 259,292,000 | added | 1.39 | ||
| PCVX | vaxcyte inc | 9.10 | 1,039,290 | 118,759,000 | added | 37.98 | ||
| PTGX | protagonist therapeutics inc | 1.57 | 456,369 | 20,536,600 | reduced | -42.95 | ||
| SNDX | syndax pharmaceuticals inc | 8.62 | 5,842,920 | 112,476,000 | added | 2.11 | ||
| STRO | sutro biopharma inc | 0.55 | 2,066,450 | 7,149,910 | added | 2.11 | ||
| TSVT | 2seventy bio inc | 2.15 | 5,953,820 | 28,102,100 | unchanged | 0.00 | ||
| TVTX | travere therapeutics inc | 1.47 | 1,371,510 | 19,187,400 | reduced | -32.16 | ||
| TYRA | tyra biosciences inc | 0.84 | 467,947 | 11,001,400 | reduced | -17.43 | ||
| VERA | vera therapeutics inc | 5.34 | 1,576,550 | 69,683,500 | added | 2.13 | ||
| VRDN | viridian therapeutics inc | 4.38 | 2,511,300 | 57,132,000 | added | 43.5 | ||